These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34666028)

  • 1. Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis.
    Basthi Mohan P; Nagaraju SP; Rangaswamy D; Musunuri B; Prabhu Attur R; Bhat G; Shailesh ; Shetty S
    Clin Chim Acta; 2021 Dec; 523():339-347. PubMed ID: 34666028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury.
    Gambino C; Piano S; Stenico M; Tonon M; Brocca A; Calvino V; Incicco S; Zeni N; Gagliardi R; Cosma C; Zaninotto M; Burra P; Cillo U; Basso D; Angeli P
    Hepatology; 2023 May; 77(5):1630-1638. PubMed ID: 36125403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Urinary Neutrophil Gelatinase-associated Lipocalin Levels in Defining the Various Etiologies of Acute Kidney Injury in Liver Cirrhosis Patients.
    Lee JH; Yoon EL; Park SE; Park JY; Choi JM; Jeon TJ; Shin WC; Choi WC
    Korean J Gastroenterol; 2019 Oct; 74(4):212-218. PubMed ID: 31650797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of urine neutrophil gelatinase-associated lipocalin and renal resistive index in patients of decompensated cirrhosis with acute kidney injury.
    George R; Sonika U; Mahajan B; Sharma A; Dalal A; Sachdeva S; Kumar A
    Dig Liver Dis; 2023 Sep; 55(9):1230-1235. PubMed ID: 37244788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.
    Belcher JM; Sanyal AJ; Peixoto AJ; Perazella MA; Lim J; Thiessen-Philbrook H; Ansari N; Coca SG; Garcia-Tsao G; Parikh CR;
    Hepatology; 2014 Aug; 60(2):622-32. PubMed ID: 24375576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Neutrophil Gelatinase-Associated Lipocalin in Cirrhotic Patients with Acute Kidney Injury.
    Hamdy HS; El-Ray A; Salaheldin M; Lasheen M; Aboul-Ezz M; Abdel-Moaty AS; Abdel-Rahim A
    Ann Hepatol; 2018 July - August ,; 17(4):624-630. PubMed ID: 29893703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections.
    Barreto R; Elia C; Solà E; Moreira R; Ariza X; Rodríguez E; Graupera I; Alfaro I; Morales-Ruiz M; Poch E; Guevara M; Fernández J; Jiménez W; Arroyo V; Ginès P
    J Hepatol; 2014 Jul; 61(1):35-42. PubMed ID: 24613364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study.
    Allegretti AS; Parada XV; Endres P; Zhao S; Krinsky S; St Hillien SA; Kalim S; Nigwekar SU; Flood JG; Nixon A; Simonetto DA; Juncos LA; Karakala N; Wadei HM; Regner KR; Belcher JM; Nadim MK; Garcia-Tsao G; Velez JCQ; Parikh SM; Chung RT;
    Clin Transl Gastroenterol; 2021 May; 12(5):e00359. PubMed ID: 33979307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Application of Kidney Biomarkers in Cirrhosis.
    Allegretti AS; Solà E; Ginès P
    Am J Kidney Dis; 2020 Nov; 76(5):710-719. PubMed ID: 32622560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions.
    Treeprasertsuk S; Wongkarnjana A; Jaruvongvanich V; Sallapant S; Tiranathanagul K; Komolmit P; Tangkijvanich P
    BMC Gastroenterol; 2015 Oct; 15():140. PubMed ID: 26474856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study.
    Huelin P; Solà E; Elia C; Solé C; Risso A; Moreira R; Carol M; Fabrellas N; Bassegoda O; Juanola A; de Prada G; Albertos S; Piano S; Graupera I; Ariza X; Napoleone L; Pose E; Filella X; Morales-Ruiz M; Rios J; Fernández J; Jiménez W; Poch E; Torres F; Ginès P
    Hepatology; 2019 Jul; 70(1):319-333. PubMed ID: 30810244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study.
    Jaques DA; Spahr L; Berra G; Poffet V; Lescuyer P; Gerstel E; Garin N; Martin PY; Ponte B
    Nephrology (Carlton); 2019 Feb; 24(2):170-180. PubMed ID: 29369449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current knowledge about biomarkers of acute kidney injury in liver cirrhosis.
    Lee HA; Seo YS
    Clin Mol Hepatol; 2022 Jan; 28(1):31-46. PubMed ID: 34333958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis.
    Verna EC; Brown RS; Farrand E; Pichardo EM; Forster CS; Sola-Del Valle DA; Adkins SH; Sise ME; Oliver JA; Radhakrishnan J; Barasch JM; Nickolas TL
    Dig Dis Sci; 2012 Sep; 57(9):2362-70. PubMed ID: 22562534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.
    Ariza X; Solà E; Elia C; Barreto R; Moreira R; Morales-Ruiz M; Graupera I; Rodríguez E; Huelin P; Solé C; Fernández J; Jiménez W; Arroyo V; Ginès P
    PLoS One; 2015; 10(6):e0128145. PubMed ID: 26042740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Kidney Injury in Liver Disease: Role of Biomarkers.
    Belcher JM
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):368-75. PubMed ID: 26311598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney biomarkers in cirrhosis.
    Francoz C; Nadim MK; Durand F
    J Hepatol; 2016 Oct; 65(4):809-824. PubMed ID: 27238754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis.
    Puthumana J; Ariza X; Belcher JM; Graupera I; Ginès P; Parikh CR
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1003-1013.e3. PubMed ID: 28013112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis.
    Fagundes C; Pépin MN; Guevara M; Barreto R; Casals G; Solà E; Pereira G; Rodríguez E; Garcia E; Prado V; Poch E; Jiménez W; Fernández J; Arroyo V; Ginès P
    J Hepatol; 2012 Aug; 57(2):267-73. PubMed ID: 22521351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome.
    Solé C; Ma AT; Solà E; Carol M; Fabrellas N; Juanola A; Napoleone L; Gratacós-Ginès J; Bassegoda O; Cervera M; Pérez M; Rubio AB; Avitabile E; Morales-Ruiz M; Graupera I; Pose E; Kamath PS; Ginès P
    Liver Int; 2021 Nov; 41(11):2729-2732. PubMed ID: 34569697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.